169 related articles for article (PubMed ID: 9744355)
1. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability.
Bhatnagar A; Vezza PR; Bryan JA; Atkins FB; Ziessman HA
J Nucl Med; 1998 Sep; 39(9):1617-20. PubMed ID: 9744355
[TBL] [Abstract][Full Text] [Related]
2. P-gp and MRP1 expression in parathyroid tumors related to histology, weight and (99m)Tc-sestamibi imaging results.
Jorna FH; Hollema H; Hendrikse HN; Bart J; Brouwers AH; Plukker JT
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):406-12. PubMed ID: 19235131
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidism.
Gupta Y; Ahmed R; Happerfield L; Pinder SE; Balan KK; Wishart GC
Br J Surg; 2007 Dec; 94(12):1491-5. PubMed ID: 17929232
[TBL] [Abstract][Full Text] [Related]
4. Preoperative detection of parathyroid adenomas with Tc-99m MIBI and Tc-99m pertechnetate scintigraphy: histopathological and biochemical correlation with Tc-99m MIBI uptake.
Akin M; Atasever T; Kurukahvecioglu O; Dogan M; Gokaslan D; Poyraz A; Koksal H; Taneri F
Bratisl Lek Listy; 2009; 110(3):166-9. PubMed ID: 19507637
[TBL] [Abstract][Full Text] [Related]
5. The sestamibi scan as a preoperative screening tool.
Norton KS; Johnson LW; Griffen FD; Burke J; Kennedy S; Aultman D; Li BD; Zibari G
Am Surg; 2002 Sep; 68(9):812-5. PubMed ID: 12356156
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.
Kao A; Shiau YC; Tsai SC; Wang JJ; Ho ST
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1012-5. PubMed ID: 12173014
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
9. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings.
Sun SS; Shiau YC; Lin CC; Kao A; Lee CC
Nucl Med Biol; 2001 Nov; 28(8):929-33. PubMed ID: 11711312
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and
Kushchayeva YS; Tella SH; Kushchayev SV; Van Nostrand D; Kulkarni K
Osteoporos Int; 2019 May; 30(5):1051-1057. PubMed ID: 30706095
[TBL] [Abstract][Full Text] [Related]
11. Dual-phase 99mTc-sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism.
Gordon L; Burkhalter W; Mah E
J Nucl Med Technol; 2002 Dec; 30(4):179-84. PubMed ID: 12446751
[TBL] [Abstract][Full Text] [Related]
12. Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue.
Mehta NY; Ruda JM; Kapadia S; Boyer PJ; Hollenbeak CS; Stack BC
Arch Otolaryngol Head Neck Surg; 2005 Jun; 131(6):493-8. PubMed ID: 15967881
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
Billy HT; Rimkus DR; Hartzman S; Latimer RG
Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
[TBL] [Abstract][Full Text] [Related]
14. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content.
Carpentier A; Jeannotte S; Verreault J; Lefebvre B; Bisson G; Mongeau CJ; Maheux P
J Nucl Med; 1998 Aug; 39(8):1441-4. PubMed ID: 9708524
[TBL] [Abstract][Full Text] [Related]
15. The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings.
Merlino JI; Ko K; Minotti A; McHenry CR
Am Surg; 2003 Mar; 69(3):225-9; discussion 229-30. PubMed ID: 12678479
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid scintigraphy with iodine-123 and 99mTc-sestamibi: imaging findings.
Burke GJ; Wei JP; Binet EF
AJR Am J Roentgenol; 1993 Dec; 161(6):1265-8. PubMed ID: 8249740
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging.
Takeuchi H; Greep NC; Hoon DS; Giuliano AE; Hansen NM; Umetani N; Singer FR
J Clin Endocrinol Metab; 2007 May; 92(5):1785-90. PubMed ID: 17299072
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies.
O'Doherty MJ; Kettle AG; Wells P; Collins RE; Coakley AJ
J Nucl Med; 1992 Mar; 33(3):313-8. PubMed ID: 1531500
[TBL] [Abstract][Full Text] [Related]
19. [False negative spect parathyroid scintigraphy with sestamibi in patients with primary hyperparathyroidism].
Paillahueque G; Massardo T; Barberán M; Ocares G; Gallegos I; Toro L; Araya AV
Rev Med Chil; 2017 Aug; 145(8):1021-1027. PubMed ID: 29189860
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
